Literature DB >> 10393836

cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.

J K Hitzler1, D P Witte, N A Jenkins, N G Copeland, D J Gilbert, C W Naeve, A T Look, S W Morris.   

Abstract

The NPM-MLF1 fusion protein is expressed in blasts from patients with myelodysplasia/acute myeloid leukemia (MDS/AML) containing the t(3;5) chromosomal rearrangement. Nucleophosmin (NPM), a previously characterized nucleolar phosphoprotein, contributes to two other fusion proteins found in lympho-hematopoietic malignancies, anaplastic large cell lymphoma (NPM-ALK) and acute promyelocytic leukemia (NPM-RARalpha). By contrast, the function of the carboxy-terminal fusion partner, myelodysplasia/myeloid leukemia factor 1 (MLF1), is unknown. To aid in understanding normal MLF1 function, we isolated the murine cDNA, determined the chromosomal localization of Mlf1, and defined its tissue expression by in situ hybridization. Mlf1 was highly similar to its human homologue (86% and 84% identical nucleotide and amino acid sequence, respectively) and mapped to the central region of chromosome 3, within a segment lacking known mouse mutations. Mlf1 tissue distribution was restricted during both development and postnatal life, with high levels present only in skeletal, cardiac, and selected smooth muscle, gonadal tissues, and rare epithelial tissues including the nasal mucosa and the ependyma/choroid plexus in the brain. Mlf1 transcripts were undetectable in the lympho-hematopoietic organs of both the embryonic and adult mouse, suggesting that NPM-MLF1 contributes to the genesis of MDS/AML in part by enforcing the ectopic overexpression of MLF1 within hematopoietic tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393836      PMCID: PMC1866665          DOI: 10.1016/S0002-9440(10)65098-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  The roles of 14-3-3 proteins in signal transduction.

Authors:  G W Reuther; A M Pendergast
Journal:  Vitam Horm       Date:  1996       Impact factor: 3.421

2.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

3.  Revised classification of acute myeloid leukemia.

Authors:  D R Head
Journal:  Leukemia       Date:  1996-11       Impact factor: 11.528

Review 4.  14-3-3: modulators of signaling proteins?

Authors:  D Morrison
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  14-3-3 proteins associate with cdc25 phosphatases.

Authors:  D S Conklin; K Galaktionov; D Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

Authors:  T R Golub; G F Barker; M Lovett; D G Gilliland
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

7.  Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.

Authors:  G W Reuther; H Fu; L D Cripe; R J Collier; A M Pendergast
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

9.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.

Authors:  A Raza; S Gezer; S Mundle; X Z Gao; S Alvi; R Borok; S Rifkin; A Iftikhar; V Shetty; A Parcharidou
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

10.  trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues.

Authors:  L Tessarollo; P Tsoulfas; D Martin-Zanca; D J Gilbert; N A Jenkins; N G Copeland; L F Parada
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  4 in total

1.  A regulatory program for excretory system regeneration in planarians.

Authors:  M Lucila Scimone; Mansi Srivastava; George W Bell; Peter W Reddien
Journal:  Development       Date:  2011-10       Impact factor: 6.868

2.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

3.  Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.

Authors:  Yi Sun; Amina Fu; Wu Xu; Jyh-Rong Chao; Simon Moshiach; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2015-11-12       Impact factor: 4.158

4.  Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd.

Authors:  Lei Zhou; Yu Liu; Li Lu; Xinzheng Lu; Richard A F Dixon
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.